Form 4 for SONM DNA X, Inc.
Accepted 2021-09-14 00:00:00 ET · period of report 2021-09-10 · accession 0000899243-21-035919 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-14 | 2021-09-10 | SONM | TIRVA ROBERT L. | Pres, CFO, COO | S - Sale | $0.67 | -6,417 | 1.04M | -0.6% | -$4,299 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-10 | S | D | 6,417 | $0.67 | 1,044,889 | D | — | — | (F1) Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. (F2) Includes 795,702 restricted stock units. |